Abstract
Clinical ThyroidologyVol. 35, No. 4 Thyroid CancerShould Serum Calcitonin Levels Be Used to Deescalate Postoperative Follow-up in Medullary Thyroid Cancer?Christopher W. RoweChristopher W. RoweDepartment of Endocrinology and Diabetes, John Hunter Hospital, Newcastle, Australia, and School of Medicine and Public Health, University of Newcastle, Callaghan, Australia.Search for more papers by this authorPublished Online:11 Apr 2023https://doi.org/10.1089/ct.2023;35.157-159AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 35Issue 4Apr 2023 Information© Copyright 2023, Mary Ann Liebert, Inc.To cite this article:Christopher W. Rowe.Should Serum Calcitonin Levels Be Used to Deescalate Postoperative Follow-up in Medullary Thyroid Cancer?.Clinical Thyroidology.Apr 2023.157-159.http://doi.org/10.1089/ct.2023;35.157-159Published in Volume: 35 Issue 4: April 11, 2023PDF download
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
